Differences between predicted cytotoxic T-Lymphocyte Epitopes of 2009 H1N1 Swine-Origin Influenza Virus compared with other H1N1 strains of 1918, 1934 and 2007 for HLA-A*0201, HLAA* 1101, and HLA-A*2402 alleles: Clinical implications

International Journal of Integrative Biology

Volumn 10, Issue 3, 2010, Pages 124-131

  Lee, Cynthia X ^a   Poh, W P ^a   Sakharkar, Kishore R ^c   Sakharkar, Meena K ^b   Chow, Vincent T K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

Author keywords

2009 H1N1 swine origin influenza virus; Cytotoxic T lymphocyte epitopes; Epitope prediction servers; H1N1 influenza strains; HLA alleles

Indexed keywords

EPITOPE; HEMAGGLUTININ; HLA A ANTIGEN; INFLUENZA VACCINE; SIALIDASE; VIRUS PROTEIN;

ALLELE; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HAPLOTYPE; HUMAN; INFLUENZA VIRUS A H1N1; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS STRAIN;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 78650832199     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bui HH, Peters B, et al. (2007) Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc. Natl. Acad. Sci. USA, 104: 246-251.
2. Chow VT, Tambyah PA, et al. (2008) To kill a mocking bird flu? Ann. Acad. Med., 37: 451-453.
3. Dawood FS, Jain S, et al. (2009) Novel Swine-Origin Influenza A (H1N1) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med., 360: 2605-2615.
4. CDC (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal Wkly Rep., 58: 521-524.
5. Chen MI, Lee VJ, et al. (2010) 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA, 303: 1383-1391.
6. Chowell G, Bertozzi SM, et al. (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N. Engl. J. Med., 361: 674-679.
7. Couch RB (2008) Seasonal inactivated influenza virus vaccines. Vaccine, 26(S4): D5-D9.
8. Cutter J, Ang LW, et al. (2010) Outbreak of pandemic influenza A (H1N1-2009) in Singapore, May to September 2009. Ann. Acad. Med., 39: 273-282.
9. De Filette M, Jou WM, et al. (2005) Universal influenza A vaccine: optimization of M2-based constructs. Virology, 337: 149-161.
10. De Filette M, Martens W, et al. (2008) An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J. Biol. Chem., 283: 11382-11387.
11. De Groot AS, Ardito M, et al. (2009) Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine, 27: 5740-5747.
12. De Groot AS, Sbai H, et al. (2002) Immuno-informatics: mining genomes for vaccine components. Immunol. Cell Biol., 80: 255-269.
13. Doherty PC and Kelso A (2008) Toward a broadly protective influenza vaccine. J. Clin. Invest., 118: 3273-3275.
14. Fu TM, Grimm KM, et al. (2008) Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys. Vaccine, 27: 1440-1447.
15. Gabriel G, Herwig A, et al. (2008) Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog., 4: e11.
16. Ge X, Tan V, et al. (2010) Assessment of seasonal influenza A virusspecific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J. Virol., 84: 3312-3319.
17. Gotch F, Rothbard J, et al. (1987) Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature, 326: 881-882.
18. Goy K, Von Bibra S, et al. (2008) Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respi. Viruses, 2: 115-125.
19. Grebe KM, Yewdell JW, et al. (2008) Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect., 10: 1024- 1029.
20. Greenberg ME, Lai MH, et al. (2009) Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine - preliminary report. N. Engl. J. Med., 361: 2405-2413.
21. Hancock K, Veguilla V, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med., 361: 1945-1952.
22. Hu J, Fu R, et al. (2007) The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain. Biophys. J., 93: 276-283.
23. Kreijtz JH, de Mutsert G, et al. (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol., 82: 5161-5166.
24. Lee LYH, Ha DLA, et al. (2008) Rowland-Jones S, Dong Tao. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest., 118: 3478-3490.
25. Lee VJ, Tok MY, et al. (2009) Economic analysis of pandemic influenza vaccination strategies in Singapore. PLoS One, 4: e7108.
26. Lin HH, Ray S, et al. (2008) Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol., 9: 8.
27. Middleton D, Williams F, et al. (2000) Analysis of the distribution of HLA-A alleles in populations from five continents. Hum. Immunol., 61: 1048-1052.
28. Middleton D, Menchaca L, et al. (2003) New alleles frequency database: http://www.allelefrequencies.net. Tissue Antigens, 61: 403- 407.
29. Morens DM, Taubenberger JK, et al. (2009) The persistent legacy of the 1918 influenza virus. N. Engl. J. Med., 361: 225-229.
30. Narasaraju T, Sim MK, et al. (2009) Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect., 11: 2-11.
31. Nayak B, Kumar S, et al. (2010) Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J. Virol., 84: 2408- 2420.
32. Ozaki H, Govorkova EA, et al. (2004) Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics. J. Virol., 78: 1851-1857.
33. Parker JMR, Guo D, et al. (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and x-rayderived accessible sites. Biochemistry, 25: 5425-5432.
34. Poh WP, Narasaraju T, et al. (2009) Characterization of cytotoxic Tlymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif. J. Med. Virol., 81: 1131-1139.
35. Rammensee HG, Bachmann J, et al. (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics, 50: 213-219.
36. Reche PA, Glutting JP, et al. (2002) Prediction of MHC class I binding peptides using profile motifs. Hum. Immunol., 63: 701-709.
37. Sakharkar MK, Sakharkar KR, et al. (2009) Human genomic diversity, viral genomics and proteomics, as exemplified by human papillomaviruses and H5N1 influenza viruses. Hum. Genomics, 3: 320-331.
38. Shinde V, Bridges CB, et al. (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N. Engl. J. Med., 360: 2616-2625.
39. Singh H and Raghava GPS (2003) ProPred1: prediction of promiscuous MHC class-I binding sites. Bioinformatics, 19: 1009- 1014.
40. Soundararajan V, Tharakaraman K, et al. (2009) Extrapolating from sequence - the 2009 H1N1 'swine' influenza virus. Nat. Biotechnol., 27: 510-513.
41. Subramony H, Lai FY, et al. (2010) An epidemiological study of 1348 cases of pandemic H1N1 influenza admitted to Singapore Hospitals from July to September 2009. Ann. Acad. Med., 39: 283- 290.
42. Vider-Shalit A, Sarid R, et al. (2009) Viruses selectively mutate their CD8+ T-cell epitopes - a large-scale immunomic analysis. Bioinformatics, 25: 39-44.
43. Wu F, Huang JH, et al. (2007) Characterization of immunity induced by M2e of influenza virus. Vaccine, 25: 8868-8873.
44. Xing Z and Cardona CJ (2009) Preexisting immunity to pandemic (H1N1) 2009. Emerg. Infect. Dis., 15: 1847-1849.
45. Zhao B, Sakharkar KR, et al. (2007) MHC-peptide binding prediction for epitope based vaccine design. Int. J. Integ, Biol., 1: 127-140.